Harvard Apparatus Regenerative Technology, Inc. (HRGN)

1.58 -0.50% (-0.01)

Over 3Y: -63.7%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4 6
2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 123K Q3 '25 — Operating Cash Flow: -1.5M Q3 '25 — Net Income: -1.7M Q4 '25 — Revenue: 219K Q4 '25 — Operating Cash Flow: -664K Q4 '25 — Net Income: -1.7M Q1 '26 — Revenue: 226K Q1 '26 — Operating Cash Flow: -937K Q1 '26 — Net Income: -1.6M Q2 '26 — Revenue: 414K Q2 '26 — Operating Cash Flow: -569K Q2 '26 — Net Income: -1.7M -1.5M -1M -500K 0 500K
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 187.7%
OE margin -557.8%
Oper. margin -683.3%
Accruals -180.9%
EBITDA margin -682.9%
FCF margin -370.2%
OCF margin -370.2%
Profit margin -680.5%
ROA -396.6%
Capex / sales —
OCF / EBIT —
ROCE —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.6
RPO / sales 0.61×
Segment HHI 0.55 HHI
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.5
ND/EBITDA —
Current ratio 0.32×
Interest cover -516.2×
Cash / Debt 33.7×
Debt payback 0.0 yr
Cash runway 0.41 yr
F-score 2.2 pts
Quick ratio 0.26×
Debt / Eq —
Equity / Assets —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.9
Sales/sh Y/Y +29.5%
Sales Q/Q +30.6%
Shares change +11.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.